Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

Go back to Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
(NASDAQ: CODX) Delayed: 1.12 +0.03 (2.75%)
Previous Close $1.09    52 Week High $ 
Open $1.09    52 Week Low $ 
Day High $1.13    P/E N/A 
Day Low $1.09    EPS $ 
Volume 111,450